{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:18:56Z","timestamp":1778858336019,"version":"3.51.4"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2007,10,26]],"date-time":"2007-10-26T00:00:00Z","timestamp":1193356800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1007\/s00262-007-0410-4","type":"journal-article","created":{"date-parts":[[2007,10,25]],"date-time":"2007-10-25T10:29:49Z","timestamp":1193308189000},"page":"701-718","source":"Crossref","is-referenced-by-count":21,"title":["Anti-inflammatory pretreatment enables an efficient dendritic cell-based immunotherapy against established tumors"],"prefix":"10.1007","volume":"57","author":[{"given":"Paula","family":"Chiarella","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marisa","family":"Vulcano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Bruzzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00f3nica","family":"Vermeulen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Vanzulli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Maglioco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela","family":"Camerano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00edctor","family":"Palacios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Romina Fern\u00e1ndez","family":"Brando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mart\u00edn A.","family":"Isturiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graciela I.","family":"Dran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oscar D.","family":"Bustuoabad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ra\u00fal A.","family":"Ruggiero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,10,26]]},"reference":[{"key":"410_CR1","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1084\/jem.20060336","volume":"203","author":"SM Abraham","year":"2006","unstructured":"Abraham SM, Lawrence T, Kleiman A, Warden P, Medghalchi M, Tuckermann J, Saklatvala J, Clark AR (2006) Antiinflammatory effects of dexamethasone are partly dependent on induction of dual specificity phosphatase I. J Exp Med 203:1883\u20131889","journal-title":"J Exp Med"},{"key":"410_CR2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/156800907780006931","volume":"7","author":"AJ Adler","year":"2007","unstructured":"Adler AJ (2007) Mechanisms of T cell tolerance and suppression in cancer mediated by tumor-associated antigens and hormones. Curr Cancer Drug Target 7:3\u201314","journal-title":"Curr Cancer Drug Target"},{"key":"410_CR3","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jcv.2006.12.009","volume":"38","author":"M Arbyn","year":"2007","unstructured":"Arbyn M, Dillner J (2007) Review of current knowledge on HPV vaccination: an appendix to the European guidelines for quality assurance in cervical cancer screening. J Clin Virol 38:189\u2013197","journal-title":"J Clin Virol"},{"key":"410_CR4","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3727\/096504005776367933","volume":"15","author":"OD Bustuoabad","year":"2005","unstructured":"Bustuoabad OD, Ruggiero RA, di Gianni P, Lombardi MG, Belli C, Camerano GV, Dran G, Schere-Levy C, Costa H, Isturiz MA, Narvaitz M, van Rooijen N, Bustuoabad VA, Meiss RP (2005) Tumor transition zone: a putative new morphological and functional hallmark of tumor aggressiveness. Oncol Res 15:169\u2013182","journal-title":"Oncol Res"},{"key":"410_CR5","doi-asserted-by":"crossref","first-page":"5313","DOI":"10.4049\/jimmunol.161.10.5313","volume":"161","author":"V Bronte","year":"1998","unstructured":"Bronte V, Wang M, Overwijk WW, Surman DR, Pericle F, Rosenberg SA, Restifo NP (1998) Apoptotic death of CD8+ T lymphocytes after immunization: induction of a suppressive population of Mac1+\/Gr1+ cells. J Immunol 161:5313\u20135320","journal-title":"J Immunol"},{"key":"410_CR6","doi-asserted-by":"crossref","first-page":"5728","DOI":"10.4049\/jimmunol.162.10.5728","volume":"162","author":"V Bronte","year":"1999","unstructured":"Bronte V, Chappell DB, Apolloni E, Cabrelle A, Wang M, Hwu P, Restifo NP (1999) Unopposed production of granulocyte\u2013macrophage colony-stimulating factor by tumors inhibits CD8+ T cell responses by dysregulating antigen-presenting cell maturation. J Immunol 162:5728\u20135737","journal-title":"J Immunol"},{"key":"410_CR7","first-page":"44","volume":"67","author":"P Chiarella","year":"2007","unstructured":"Chiarella P, Vulcano M, Laborde E, Vermeulen M, Bruzzo J, Rearte B, Bustuoabad OD, Ruggiero RA (2007) Reversion of the immunological eclipse and therapeutic vaccination against cancer in an experimental model [Article in Spanish]. Medicina (Bs. As.) 67:44\u201348","journal-title":"Medicina (Bs. As.)"},{"key":"410_CR8","first-page":"320:3","volume-title":"Current protocols in immunology, National Institute of Health, USA","author":"J Coligan","year":"1994","unstructured":"Coligan J, Knisblek A, Margulies D, Shevach E, Warren S (1994) In vitro assays for mouse lymphocyte function. In: Coligan J, Knisblek A, Margulies D et al (eds) Current protocols in immunology, National Institute of Health, USA. Wiley, New York, pp 3.20:3\u20133.20:4"},{"key":"410_CR9","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00262-003-0432-5","volume":"53","author":"LD Cranmer","year":"2004","unstructured":"Cranmer LD, Trevor KT, Hersh EM (2004) Clinical applications of dendritic cell vaccination in the treatment of cancer. Cancer Immmunol Immunother 53:275\u2013306","journal-title":"Cancer Immmunol Immunother"},{"key":"410_CR10","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1182\/blood.V97.2.339","volume":"97","author":"E Di Carlo","year":"2001","unstructured":"Di Carlo E, Forni G, Lollini P, Colombo MP, Modesti A, Musiani P (2001) The intriguing role of polymorphonuclear neutrophils in antitumor reactions. Blood 97:339\u2013345","journal-title":"Blood"},{"key":"410_CR11","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/nri1150","volume":"3","author":"OJ Finn","year":"2003","unstructured":"Finn OJ (2003) Cancer vaccines: between the idea and the reality. Nat Rev Immunol 3:630\u2013641","journal-title":"Nat Rev Immunol"},{"key":"410_CR12","first-page":"835","volume":"13","author":"EJ Foley","year":"1953","unstructured":"Foley EJ (1953) Antigenic properties of methylcholanthrene-induced tumors in mice of the strain of origin. Cancer Res 13:835\u2013837","journal-title":"Cancer Res"},{"key":"410_CR13","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/bjc.1996.335","volume":"74","author":"M Franco","year":"1996","unstructured":"Franco M, Bustuoabad OD, di Gianni PD, Goldman A, Pasqualini CD, Ruggiero RA (1996) A serum-mediated mechanism for concomitant resistance shared by immunogenic and non-immunogenic murine tumours. Br J Cancer 74:178\u2013186","journal-title":"Br J Cancer"},{"key":"410_CR14","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0065-230X(08)61033-7","volume":"39","author":"E Gorelik","year":"1983","unstructured":"Gorelik E (1983) Concomitant tumor immunity and the resistance to a second tumor challenge. Adv Cancer Res 39:71\u2013120","journal-title":"Adv Cancer Res"},{"key":"410_CR15","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1002\/1521-4141(200211)32:11<3235::AID-IMMU3235>3.0.CO;2-J","volume":"32","author":"K Heckelsmiller","year":"2002","unstructured":"Heckelsmiller K, Beck S, Rall K, Sipos B, Schlamp A, Tuma E, Rothenfusser S, Endres S, Hartmann G (2002) Combined dendritic cell-and CpG oligonucleotide- based immune therapy cures large murine tumors that resist chemotherapy. Eur J Immunol 32:3235\u20133245","journal-title":"Eur J Immunol"},{"key":"410_CR16","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/bjc.1976.37","volume":"33","author":"HB Hewitt","year":"1976","unstructured":"Hewitt HB, Blake ER, Walder AS (1976) A critique of the evidence for active host defence against cancer based on personal studies of 27 murine tumours of spontaneous origin. Br J Cancer 33:241\u2013259","journal-title":"Br J Cancer"},{"key":"410_CR17","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/BF00199141","volume":"25","author":"Y Hiramoto","year":"1987","unstructured":"Hiramoto Y, Sugimachi K (1987) Effect of glucocorticoid deficiency after adrenalectomy on antitumor immunity. Cancer Immunol Immunother 25:157\u2013160","journal-title":"Cancer Immunol Immunother"},{"key":"410_CR18","doi-asserted-by":"crossref","first-page":"47444","DOI":"10.1074\/jbc.M208140200","volume":"277","author":"A Imasato","year":"2002","unstructured":"Imasato A, Desbois-Mouthon C, Han J, Kai H, Cato AC, Akira S, Li JD (2002) Inhibition of p38 MAPK by glucocorticoids via induction of MAPK phosphatase-1 enhances nontypeable Haemophilus influenzae induced expression of toll-like receptor 2. J Biol Chem 277:47444\u201347450","journal-title":"J Biol Chem"},{"key":"410_CR19","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2174\/156800907780006878","volume":"7","author":"BA Inman","year":"2007","unstructured":"Inman BA, Frigola X, Donq H, Kwon ED (2007) Costimulation, coinhibition and cancer. Curr Cancer Drug Targets 7:15\u201330","journal-title":"Curr Cancer Drug Targets"},{"key":"410_CR20","unstructured":"Janeway CA, Travers P, Walport M, Shlomckik MJ (2001) Manipulation of the immune response. In: Immunobiology. Garland, New York, pp 566\u2013577"},{"key":"410_CR21","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0006-291X(88)81232-4","volume":"153","author":"MY Kalimi","year":"1988","unstructured":"Kalimi MY, Agarwal MK (1988) Interaction of antiglucocorticoid RU-486 with rat kidney glucocorticoid receptor. Biochem Biophys Res Commun 153:365\u2013371","journal-title":"Biochem Biophys Res Commun"},{"key":"410_CR22","first-page":"1561","volume":"20","author":"G Klein","year":"1960","unstructured":"Klein G, Sj\u00f6gren HO, Klein E, Hellstr\u00f6m KE (1960) Demonstration of resistance against methylcholanthrene-induced sarcomas in the primary autochthonous host. Cancer Res 20:1561\u20131572","journal-title":"Cancer Res"},{"key":"410_CR23","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1084\/jem.20050940","volume":"202","author":"K Ko","year":"2005","unstructured":"Ko K, Yamazaki S, Nakamura K, Nishioka T, Hirota K, Yamaguchi T, Shimizu J, Nomura T, Chiba T, Sakaguchi S (2005) Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3+ CD4+CD25+ T regulatory cells. J Exp Med 202:885\u2013891","journal-title":"J Exp Med"},{"key":"410_CR24","doi-asserted-by":"crossref","unstructured":"Kuang DM, Wu Y, Chen N, Cheng J, Zhuang SM, Zheng L (2007) Tumor-derived hyaluronan induces formation of immunosuppressive macrophages. Blood. doi: 10.1182\/blood-2007-01-068031","DOI":"10.1182\/blood-2007-01-068031"},{"key":"410_CR25","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00262-005-0048-z","volume":"55","author":"S Kusmartsev","year":"2006","unstructured":"Kusmartsev S, Gabrilovich DI (2006) Role of immature myeloid cells in mechanisms of immune evasion in cancer. Cancer Immunol Immunother 55:237\u2013245","journal-title":"Cancer Immunol Immunother"},{"key":"410_CR26","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1158\/0008-5472.CAN-06-3014","volume":"67","author":"KY Lin","year":"2007","unstructured":"Lin KY, Lu D, Huang CF, Peng S, Huang L, Jie C, Murillo F, Rowley J, Tsai YC, He L, Kim DJ, Jaffee E, Pardoll D, Wu TC (2007) Ectopic expression of vascular cell adhesion molecule-1 as a new mechanism for tumor immune evasion. Cancer Res 67:1832\u20131841","journal-title":"Cancer Res"},{"key":"410_CR27","first-page":"2048","volume":"49","author":"Y Maehara","year":"1989","unstructured":"Maehara Y, Hiramoto Y, Akazawa K, Sakaguchi Y, Tamada R, Sugimachi K (1989) Effect of glucocorticoid replacement on tumor growth alter adrenalectomy in mice. Cancer Res 49:2048\u20132051","journal-title":"Cancer Res"},{"key":"410_CR28","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1038\/nm1295-1297","volume":"1","author":"JI Mayordomo","year":"1995","unstructured":"Mayordomo JI, Zorina T, Storkus WJ, Zitvogel L, Celluzzi C, Falo LD, Melief CJ, Ildstad ST, Kast WM, Deleo AB, Lotze MT (1995) Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumor immunity. Nat Med 1:1297\u20131302","journal-title":"Nat Med"},{"key":"410_CR29","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/BF00118469","volume":"1","author":"C Meyvisch","year":"1983","unstructured":"Meyvisch C, Storme GA, Bruyneel E, Mareel MM (1983) Invasiveness and tumorigenicity of MO4 mouse fibrosarcoma cells pretreated with microtubule inhibitors. Clin Exp Metastasis 1:17\u201328","journal-title":"Clin Exp Metastasis"},{"key":"410_CR30","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S1470-2045(04)01610-9","volume":"5","author":"S Mocellin","year":"2004","unstructured":"Mocellin S, Mandruzzato S, Bronte V, Lise M, Nitti D (2004) Part 1: Vaccines for solid tumors. Lancet Oncol 5:681\u2013689","journal-title":"Lancet Oncol"},{"key":"410_CR31","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.4049\/jimmunol.151.3.1548","volume":"151","author":"KM Mohler","year":"1993","unstructured":"Mohler KM, Torrance DS, Smith CA, Goodwin RG, Stremler KE, Fung VP, Madani H, Widmer MB (1993) Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists. J Immunol 151:1548\u20131561","journal-title":"J Immunol"},{"key":"410_CR32","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1126\/science.1129003","volume":"314","author":"RA Morgan","year":"2006","unstructured":"Morgan RA, Dudley ME, Wunderlich JR, Hughes MS, Yang JC, Sherry RM, Royal RE, Topalian SL, Kammula US, Restifo NP, Zheng Z, Nahvi A, de Vries CR, Roger-Freezer LJ, Mavroukakis SA, Rosenberg SA (2006) Cancer regression in patients after transfer of genetically engineered lymphocytes. Science 314:126\u2013129","journal-title":"Science"},{"key":"410_CR33","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/nrc1929","volume":"6","author":"AJ Muller","year":"2006","unstructured":"Muller AJ, Scherle PA (2006) Targeting the mechanisms of tumoral immune tolerance with small-molecule inhibitors. Nature Rev Cancer 6:613\u2013625","journal-title":"Nature Rev Cancer"},{"key":"410_CR34","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/nature01320","volume":"420","author":"C Nathan","year":"2002","unstructured":"Nathan C (2002) Points of Control in inflammation. Nature 420:846\u2013852","journal-title":"Nature"},{"key":"410_CR35","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1189\/jlb.1105646","volume":"80","author":"D Nelson","year":"2006","unstructured":"Nelson D, Ganss R (2006) Tumor growth or regression: powered by inflammation. J Leukoc Biol 80:685\u2013690","journal-title":"J Leukoc Biol"},{"key":"410_CR36","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0065-2776(08)60575-1","volume":"35","author":"RJ North","year":"1984","unstructured":"North RJ (1984) The murine antitumor immune response and its therapeutic manipulation. Adv Immunol 35:89\u2013155","journal-title":"Adv Immunol"},{"key":"410_CR37","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/35082583","volume":"411","author":"AF Ochsenbein","year":"2001","unstructured":"Ochsenbein AF, Sierro S, Odermatt B, Pericin M, Karrer U, Hermans J, Hemmi S, Hengartner H, Zinkernagel RM (2001) Roles of tumour localization, second signals and cross priming in cytotoxic T cell induction. Nature 411:1058\u20131064","journal-title":"Nature"},{"key":"410_CR38","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1126\/science.1133893","volume":"314","author":"R Offringa","year":"2006","unstructured":"Offringa R (2006) Cancer: enhanced: cancer immunotherapy is more than a number game. Science 314:68\u201369","journal-title":"Science"},{"key":"410_CR39","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.semcancer.2005.11.007","volume":"16","author":"RJ Orentas","year":"2006","unstructured":"Orentas RJ, Kohler ME, Johnson BD (2006) Suppression of anti-cancer immunity by regulatory T cells: back to the future. Semin Cancer Biol 16:137\u2013139","journal-title":"Semin Cancer Biol"},{"key":"410_CR40","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1084\/jem.181.1.435","volume":"181","author":"LA Pekarek","year":"1995","unstructured":"Pekarek LA, Starr B, Toledano A, Schreiber H (1995) Inhibition of tumor growth by elimination of granulocytes. J Exp Med 181:435\u2013440","journal-title":"J Exp Med"},{"key":"410_CR41","doi-asserted-by":"crossref","first-page":"3767","DOI":"10.1158\/0008-5472.CAN-04-0668","volume":"64","author":"C Perrotta","year":"2004","unstructured":"Perrotta C, Falcone S, Capobianco A, Camporeale A, Sciorati C, De Palma C, Pisconti A, Rovere-Querini P, Bellone M, Manfredi AA, Clementi E (2004) Nitric oxide confers therapeutic activity to dendritic cells in a mouse model of melanoma. Cancer Res 64:3767\u20133771","journal-title":"Cancer Res"},{"key":"410_CR42","first-page":"769","volume":"18","author":"RT Prehn","year":"1957","unstructured":"Prehn RT, Main JM (1957) Immunity to methylcholanthrene-induced sarcomas. J Natl Cancer Inst 18:769\u2013778","journal-title":"J Natl Cancer Inst"},{"key":"410_CR43","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1126\/science.176.4031.170","volume":"176","author":"RT Prehn","year":"1972","unstructured":"Prehn RT (1972) The immune reaction as a stimulator of tumor growth Science 176:170\u2013171","journal-title":"Science"},{"key":"410_CR44","first-page":"3266","volume":"53","author":"RT Prehn","year":"1993","unstructured":"Prehn RT (1993) Two competing influences that may explain concomitant tumor resistance. Cancer Res 53:3266\u20133269","journal-title":"Cancer Res"},{"key":"410_CR45","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1742-4682-3-6","volume":"3","author":"RT Prehn","year":"2006","unstructured":"Prehn RT (2006) An adaptive immune reaction may be necessary for cancer development. Theor Biol Med Model 3:6","journal-title":"Theor Biol Med Model"},{"key":"410_CR46","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1742-4682-4-6","volume":"4","author":"RT Prehn","year":"2007","unstructured":"Prehn RT (2007) Immunostimulation and immunonoinhibition of premalignant lesions. Theor Biol Med Model 4:6","journal-title":"Theor Biol Med Model"},{"key":"410_CR47","doi-asserted-by":"crossref","first-page":"10555","DOI":"10.1158\/0008-5472.CAN-05-0627","volume":"65","author":"GR Rossi","year":"2005","unstructured":"Rossi GR, Mautino MR, Unfer RC, Seregina TM, Vahanian N, Link CJ (2005) Effective treatment of preexisting melanoma with whole cell vaccines expressing \u03b1 (1,3)-galactosyl epitopes. Cancer Res 65:10555\u201310561","journal-title":"Cancer Res"},{"key":"410_CR48","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1535-6108(04)00024-8","volume":"5","author":"N Rubinstein","year":"2004","unstructured":"Rubinstein N, Alvarez M, Zwirner NW, Toscano MA, Ilarregui JM, Bravo A, Mordoh J, Fainboin L, Podhajcer OL, Rabinovich GA (2004) Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection: a potential mechanism of tumor-immune privilege. Cancer Cell 5:241\u2013251","journal-title":"Cancer Cell"},{"key":"410_CR49","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/bjc.1985.6","volume":"51","author":"RA Ruggiero","year":"1985","unstructured":"Ruggiero RA, Bustuoabad OD, Bonfil RD, Meiss RP, Pasqualini CD (1985) \u201cConcomitant immunity\u201d in murine tumors of non-detectable immunogenicity. Br J Cancer 51:37\u201348","journal-title":"Br J Cancer"},{"key":"410_CR50","first-page":"7159","volume":"50","author":"RA Ruggiero","year":"1990","unstructured":"Ruggiero RA, Bustuoabad OD, Cramer P, Bonfil RD, Pasqualini CD (1990) Correlation between seric antitumor activity and concomitant resistance in mice bearing nonimmunogenic tumors. Cancer Res 50:7159\u20137165","journal-title":"Cancer Res"},{"key":"410_CR51","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1742-4682-3-43","volume":"3","author":"RA Ruggiero","year":"2006","unstructured":"Ruggiero RA, Bustuoabad OD (2006) The biological sense of cancer: a hypothesis. Theor Biol Med Model 3:43","journal-title":"Theor Biol Med Model"},{"key":"410_CR52","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.4049\/jimmunol.164.4.2214","volume":"164","author":"S Salvadori","year":"2000","unstructured":"Salvadori S, Martinelli G, Zier K (2000) Resection of solid tumors reverses T cell defects and restores protective immunity. J Immunol 164:2214\u20132220","journal-title":"J Immunol"},{"key":"410_CR53","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/nri1867","volume":"6","author":"EM Shevach","year":"2006","unstructured":"Shevach EM, Stephens GL (2006) The GITR-GITRL interaction: co-stimulation or contrasuppression of regulatory activity? Nat Rev Immunol 6:613\u2013618","journal-title":"Nat Rev Immunol"},{"key":"410_CR54","first-page":"277","volume":"360","author":"M Sioud","year":"2007","unstructured":"Sioud M (2007) An overview of the immune system and technical advances in tumor antigen discovery and validation. Methods Mol Biol 360:277\u2013318","journal-title":"Methods Mol Biol"},{"key":"410_CR55","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1084\/jem.186.5.645","volume":"186","author":"DE Speiser","year":"1997","unstructured":"Speiser DE, Miranda R, Zakarian A, Bachmann MF, McKall-Faienza K, Odermatt B, Hanahan D, Zinkernagel RM, Ohashi PS (1997) Self antigens expressed by solid tumors do not efficiently stimulate na\u00efve or activated T cells: implications for immunotherapy. J Exp Med 186:645\u2013653","journal-title":"J Exp Med"},{"key":"410_CR56","doi-asserted-by":"crossref","first-page":"793","DOI":"10.2353\/ajpath.2007.060929","volume":"170","author":"JE Talmadge","year":"2007","unstructured":"Talmadge JE, Singh RK, Fidler IJ, Raz A (2007) Murine models to evaluate novel and conventional therapeutic strategies for cancer. Am J Pathol 170:793\u2013804","journal-title":"Am J Pathol"},{"key":"410_CR57","first-page":"3339","volume":"50","author":"BA Teicher","year":"1990","unstructured":"Teicher BA, Holden SA, Al-Achi A, Herman TS (1990) Classification of antineoplastic treatments by their differential toxicity toward putative oxygenated and hypoxic tumor subpopulations in vivo in the FSaIIC murine fibrosarcoma. Cancer Res 50:3339\u20133344","journal-title":"Cancer Res"},{"key":"410_CR58","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1158\/1078-0432.CCR-06-1924","volume":"13","author":"J Vieweg","year":"2007","unstructured":"Vieweg J, Su Z, Dahm P, Kusmartsev S (2007) Reversal of tumor-mediated immunosuppression. Clin Cancer Res 13:727\u2013732","journal-title":"Clin Cancer Res"},{"key":"410_CR59","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/ni1180","volume":"4","author":"H Boehmer Von","year":"2005","unstructured":"Von Boehmer H (2005) Mechanisms of suppression by suppressor T cells. Nat Immunol 4:338\u2013344","journal-title":"Nat Immunol"},{"key":"410_CR60","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nm0303-269","volume":"3","author":"TA Waldman","year":"2003","unstructured":"Waldman TA (2003) Immunotherapy: past, present and future. Nat Med 3:269\u2013277","journal-title":"Nat Med"},{"key":"410_CR61","first-page":"97","volume-title":"Principles of Pathology","author":"PA Ward","year":"1975","unstructured":"Ward PA (1975) Inflammation. In: LaVia MF, Hill RB Jr (eds) Principles of Pathology, 2nd edn. Oxford University Press, New York, pp 97\u2013140","edition":"2"},{"key":"410_CR62","first-page":"1151","volume":"5","author":"B Watson","year":"2002","unstructured":"Watson B (2002) TNF inhibitors: a review of the recent patent literature. I Drugs 5:1151\u20131161","journal-title":"I Drugs"},{"key":"410_CR63","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S0167-5699(97)01111-0","volume":"18","author":"T Wilckens","year":"1997","unstructured":"Wilckens T, De Rijk R (1997) Glucocorticoids and immune function: unknown dimensions and new frontiers. Immunol Today 18:418\u2013424","journal-title":"Immunol Today"},{"key":"410_CR64","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nature03954","volume":"437","author":"G Willimsky","year":"2005","unstructured":"Willimsky G, Blankenstein T (2005) Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance. Nature 437:141\u2013146","journal-title":"Nature"},{"key":"410_CR65","doi-asserted-by":"crossref","first-page":"228","DOI":"10.4049\/jimmunol.86.2.228","volume":"86","author":"HJ Winn","year":"1961","unstructured":"Winn HJ (1961) Immune mechanisms in homotransplantations: II. Quantitative assay of the immunological activity of lymphoid cells stimulated by tumor homograft. J Immunol 86:228\u2013239","journal-title":"J Immunol"},{"key":"410_CR66","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.coi.2006.01.004","volume":"18","author":"P Yu","year":"2006","unstructured":"Yu P, Rowley DA, Fu YX, Schreiber H (2006) The role of stroma in immune recognition and destruction of well-established tumors. Curr Opin Immunol 18:226\u2013231","journal-title":"Curr Opin Immunol"},{"key":"410_CR67","doi-asserted-by":"crossref","first-page":"5639","DOI":"10.4049\/jimmunol.177.8.5639","volume":"177","author":"X Zheng","year":"2006","unstructured":"Zheng X, Koropatnick J, Li M, Zhang X, Ling F, Ren X, Hao X, Sun H, Vladau C, Franek JA, Feng B, Urquhart BL, Zhong R, Freeman DJ, Garc\u00eda B, Min WP (2006) Reinstalling antitumor immunity by inhibiting tumor-derived immunosuppressive molecule IDO through RNA interference. J Immunol 177:5639\u20135646","journal-title":"J Immunol"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-007-0410-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00262-007-0410-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-007-0410-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,14]],"date-time":"2023-05-14T14:06:52Z","timestamp":1684073212000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00262-007-0410-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10,26]]},"references-count":67,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["410"],"URL":"https:\/\/doi.org\/10.1007\/s00262-007-0410-4","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,10,26]]}}}